# Pharmacokinetics of VVN461 Ophthalmic Solution

> **NCT06906198** · PHASE1 · COMPLETED · sponsor: **VivaVision Biotech, Inc** · enrollment: 30 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** VVN461 Ophthalmic Solution 1.0%
- **DRUG:** VVN461 Ophthalmic Solution 0.5%
- **DRUG:** VVN461 Ophthalmic Solution 0.25%
- **DRUG:** VVN461 Ophthalmic Solution Placebo

## Key facts

- **NCT ID:** NCT06906198
- **Lead sponsor:** VivaVision Biotech, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-01
- **Primary completion:** 2023-05-10
- **Final completion:** 2023-12-22
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2025-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06906198

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06906198, "Pharmacokinetics of VVN461 Ophthalmic Solution". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06906198. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*